COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1573: Articles 15721-15730  | Next

Discrete immune response signature to SARS-CoV-2 mRNA vaccination versus infection
Ivanova, E. N., Devlin, J. C., Buus, T. B., Koide, A., Cornelius, A., Samanovic, M. I., Herrera, A., Zhang, C., Desvignes, L., Odum, N., Ulrich, R., Mulligan, M. J., Koide, S., Ruggle, K. V., Herati, R. S., Koralov, S. B.
10.1101/2021.04.20.21255677 — Posted: 2021-04-21 Discussion: Onsite
Effectiveness of the BNT162b2 vaccine in preventing COVID-19 in the working age population - first results from a cohort study in Southern Sweden
Bjork, J., Inghammar, M., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Kahn, F.
10.1101/2021.04.20.21254636 — Posted: 2021-04-21 Discussion: Onsite
Multifactorial SARS-CoV-2 seroprofiling dissects interdependencies with human coronaviruses and predicts neutralization activity
Abela, I. A., Pasin, C., Schwarzmueller, M., Epp, S., Sickmann, M., Schanz, M. M., Rusert, P., Weber, J., Schmutz, S., Audige, A., Maliqi, L., Hunziker, A., Hesselman, M. C., Niklaus, C. R., Gottschalk, J., Schindler, E., Wepf, A., Karrer, U., Wolfensberger, A., Rampini, S. K., Meyer Sauteur, P. M., Berger, C., Huber, M., Boeni, J., Braun, D. L., Marconato, M., Manz, M. G., Frey, B. M., Guenthard, H. F., Kouyos, R. D., Trkola, A.
10.1101/2021.04.21.21255410 — Posted: 2021-04-21
Measuring Oxygen Access: lessons from health facility assessments in Nigeria
Graham, H. R., Olojede, O. E., Bakare, A. A., Iuliano, A., Olatunde, O., Isah, A., Osebi, A., Ahmed, T., Burgess, R., McCollum, E. D., Colbourn, T., King, C., Uchendu, O. C., Falade, A. G., INSPIRING Project Consortium
10.1101/2021.04.21.21255772 — Posted: 2021-04-21
Antibody Conversion rates to SARS-CoV-2 in Saliva from Children Attending Summer Schools in Barcelona, Spain
Dobano, C., Selena, A., Fernandez de Sevilla, M., Vidal, M., Jimenez, A., Pons Tomas, G., Jairoce, C., Mele Casas, M., Rubio, R., Hernandez Garcia, M., Ruiz-Olalla, G., Girona-Alarcon, M., Barrios, D., Santano, R., Mitchell, R. A., Puyol, L., Mayer, L., Chi, J., Rodrigo Melero, N., Carolis, C., Garcia-Miquel, A., Bonet-Carne, E., Claverol, J., Marta Cubells, M. C., Fortuny, C., Fumado, V., Jou, C., Munoz-Almagro, C., Izquierdo, L., Bassat, Q., Gratacos, E., Aguilar, R., Garcia-Garcia, J. J., Moncunill, G., Jordan, I.
10.1101/2021.04.20.440593 — Posted: 2021-04-20
Infants have lower RT-PCR cycle threshold for SARS-CoV-2 in comparison with older children and adults
Polese-Bonatto, M., Sartor, I. T. S., Hammes-Varela, F., Gianinni, G. L. T., Azevedo, T. R., Fernandes, I. R., Zavaglia, G. O., Kern, L. B., Santos, A. P., de David, C. N., de Almeida, W. A. F., Porto, V. B. G., Scotta, M. C., Stein, R. T.
10.1101/2021.04.20.21255059 — Posted: 2021-04-20
Health Belief, Planned Behavior, or Psychological Antecedents: What predicts COVID-19 Vaccine Hesitancy better among the Bangladeshi Adults?
Hossain, M. B., Alam, M. Z., Islam, M. S., Sultan, S., Faysal, M. M., Rima, S., Hossain, M. A., Mamun, A. A.
10.1101/2021.04.19.21255578 — Posted: 2021-04-20
Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled study
Stanevich, O. V., Fomina, D. S., Bakulin, I. G., Galeev, S. I., Bakin, E. A., Belash, V. A., Kulikov, A. N., Lebedeva, A. A., Lioznov, D. A., Polushin, Y. S., Shlyk, I. V., Vorobyev, E. A., Vorobyeva, S. V., Surovceva, T. V., Bakulina, N. V., Lysenko, M. A., Moiseev, I. S.
10.1101/2021.04.20.21255662 — Posted: 2021-04-20
Prevalence of severe adverse events in health professionals after receiving the first dose of the COVID-19 vaccination in Togo, March 2021
KONU, Y. R., Gbeasor-Komlanvi, F., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I., Nayo-Apetsianyi, J., Afanvi, K., Agoro, S., Salou, M., Landoh, D. E., Nyansa, A., Boko, E., Mijiyawa, M., Ekouevi, D. K.
10.1101/2021.04.20.21254863 — Posted: 2021-04-20
Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors In Vitro and In Vivo.
Patten, J., Keiser, P. T., Gysi, D. M., Menichetti, G., Mori, H., Donahue, C. J., Gan, X., do Valle, I. F., Geoghegan-Barek, K., Anantpadma, M., Berrigan, J. L., Jalloh, S. C., Ayazika, K. T., Wagner, F., Zitnik, M., Ayehunie, S., Anderson, D., Loscalzo, J., Gummuluru, S., Namchuk, M. N., Barabasi, A.-L., Davey, R. A.
10.1101/2021.04.20.440626 — Posted: 2021-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).